Related Experiment Video
Updated: Apr 1, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Hospitalized Heart Failure in the United States: Lessons Learned from Clinical Trial Populations
Stephen J Greene1, Lora AlKhawam2, Andrew P Ambrosy1
1Division of Cardiology, Department of Medicine, Duke University Medical Center, 2301 Erwin Road, Durham, NC 27705, USA.
Abstract:
Hospitalized heart failure (HHF) patients carry a prognosis comparable to many cancers and constitute more than 1 million hospital admissions annually in the United States. To date, North Americans have comprised a minority of those included in prior hospitalized HF trials and have been repeatedly shown to differ from patients in other areas of the world in terms of clinical characteristics, length of hospital stay, therapy utilization, and post-discharge outcomes. Recognizing the varying patient profiles and outcomes of North Americans enrolled in prior HHF trial programs is critical to optimizing design of future drug development programs and maximizing chances of bringing a novel therapeutic agent to the bedside.
More Related Videos
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Related Concept Videos
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Heart Failure VII: Nursing Interventions
Heart Failure V: Medical Management
Heart Failure III: Clinical Manifestations